(CALGB 20202) Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
Description: 

The purpose of this study is to examine the particular features of AML cells and certain chromosomes, genes and proteins within these cells.

Study Number: 

NCG 149209

Phase: 
NA
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00900224

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.